Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APOP

Cellect Biotechnology (APOP) Stock Price, News & Analysis

Cellect Biotechnology logo

About Cellect Biotechnology Stock (NASDAQ:APOP)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
$7.54
$13.40
52-Week Range
N/A
Volume
17,400 shs
Average Volume
479,845 shs
Market Capitalization
$12.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.

Remove Ads
Receive APOP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

APOP Stock News Headlines

Elon Tax Shock?
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.
Krystal Biotech Inc.
Raleigh/Durham Biotech News
See More Headlines

APOP Stock Analysis - Frequently Asked Questions

Cellect Biotechnology Ltd. (NASDAQ:APOP) posted its earnings results on Tuesday, November, 13th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by $0.02.

Shares of Cellect Biotechnology split on Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly created shares were issued to shareholders after the closing bell on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Advanced Micro Devices (AMD), NVIDIA (NVDA), Acasti Pharma (ACST) and Corbus Pharmaceuticals (CRBP).

Company Calendar

Last Earnings
11/13/2018
Today
4/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:APOP
Employees
2,020
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.77 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$12.87 million
Optionable
Not Optionable
Beta
1.87

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:APOP) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners